ImageneBio (IMA) Other Non Operating Income (2020 - 2025)
ImageneBio's (IMA) quarterly Other Non Operating Income came in at $1.8 million in Q3 2025, up 253.98% year-on-year from $518953.6 in Q3 2024, and down 60.98% quarter-over-quarter from $4.7 million in Q2 2025.
ImageneBio (IMA) Other Non Operating Income (2020 - 2025) Analysis & Trends
ImageneBio has disclosed Other Non Operating Income across 6 years of filings, most recently posting $1.8 million for Q3 2025.
- Other Non Operating Income for Q3 2025 came in at $1.8 million, up 253.98% year-over-year; the trailing twelve-month figure through Sep 2025 was $10.3 million (up 1152.09% YoY), and the FY2024 annual result was $2.5 million, up 11545.45% from the prior year.
- Other Non Operating Income came in at $1.8 million for Q3 2025 at ImageneBio, down from $4.7 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $4.7 million in Q2 2025 to a low of -$1.2 million in Q3 2024.
- The 5-year median for Other Non Operating Income is $6000.0 (2021), against an average of $624578.9.
- Peak annual rise in Other Non Operating Income reached 26957.14% in 2024, while the deepest fall reached 59550.0% in 2024.
- ImageneBio's Other Non Operating Income stood at $5000.0 in 2021, then surged by 20240.0% to $1.0 million in 2022, then slumped by 101.38% to -$14000.0 in 2023, then soared by 26957.14% to $3.8 million in 2024, then plunged by 51.14% to $1.8 million in 2025.
- The last three Other Non Operating Income figures came in at $1.8 million (Q3 2025), $4.7 million (Q2 2025), and -$5000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | ImageneBio | 3.18 Mn | 3.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.84 Mn |
| Jun 30, 2025 | 4.71 Mn |
| Mar 31, 2025 | -5,000.00 |
| Dec 31, 2024 | 3.76 Mn |
| Sep 30, 2024 | -1.19 Mn |
| Jun 30, 2024 | 235,000.00 |
| Mar 31, 2024 | -7,000.00 |
| Dec 31, 2023 | -14,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Jun 30, 2023 | -6,000.00 |
| Mar 31, 2023 | 566,000.00 |
| Dec 31, 2022 | 1.02 Mn |
| Sep 30, 2022 | 538,000.00 |
| Jun 30, 2022 | 460,000.00 |
| Mar 31, 2022 | -49,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 7,000.00 |
| Jun 30, 2021 | 6,000.00 |
| Mar 31, 2021 | 4,000.00 |
| Dec 31, 2020 | 2,000.00 |